Loading clinical trials...
Loading clinical trials...
A Randomized, Open Label, Non-inferiority Study to Compare the Safety and Efficacy of BOR15001L7 to Docosanol 10% in Patients With Recurrent Herpes Labialis
Conditions
Interventions
BOR15001L7
Docosanol Cream 10%
Start Date
September 1, 2020
Primary Completion Date
July 1, 2021
Completion Date
July 1, 2022
Last Updated
September 7, 2020
Lead Sponsor
Laboratoire Boreaderme Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions